RITU KAPOOR: Open Payments
NPI 1417373820 · PEACHTREE CORNERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 53 payments from 20 companies in 2025. Trend: 2023 $462 · 2024 $1,446 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $154 |
| Novo Nordisk Inc | 9 | $139 |
| AstraZeneca Pharmaceuticals LP | 7 | $135 |
| GlaxoSmithKline, LLC. | 6 | $133 |
| Lilly USA, LLC | 2 | $42 |
| Amgen Inc. | 2 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
Products named: TRELEGY ELLIPTA, Wegovy, FARXIGA, QULIPTA, AIRSUPRA, Ozempic, VRAYLAR, UBRELVY.
Industry payments across GA — which companies pay providers there.
